Intravenous immunoglobulin: Effect on infertility and recurrent pregnancy loss

Israel Medical Association Journal

Volumn 9, Issue 12, 2007, Pages 877-880

  Carp, Howard J A ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Infertility; Intravenous immunoglobulin; Pregnancy loss

Indexed keywords

ACETYLSALICYLIC ACID; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; IMMUNOGLOBULIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANEUPLOIDY; ANTIPHOSPHOLIPID SYNDROME; CHROMOSOME ABERRATION; CLINICAL TRIAL; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFICACY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; IMMUNOPATHOGENESIS; INTRAUTERINE GROWTH RETARDATION; KARYOTYPING; LIVE BIRTH; NONHUMAN; PATIENT SELECTION; PREECLAMPSIA; PREGNANCY RATE; PREMATURITY; RECURRENT ABORTION; REVIEW; TREATMENT FAILURE;

ABORTION, HABITUAL; ANTIPHOSPHOLIPID SYNDROME; CHROMOSOME ABERRATIONS; CYTOKINES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; INFERTILITY; PREGNANCY;

EID: 37849033854     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Carp HJA, Sapir T, Shoenfeld Y. Intravenous immunoglobulin and recurrent pregnancy loss. Clin Rev Allergy lmmunol 2005;29:327-32.
2. Clark DA, Chaouat G. Loss of surface CD200 on stored allogeneic leukocytes may impair anti-abortive effect in vivo. Am J Reprod Immunol 2005;53:13-20.
3. Gorczynski RM. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.. Transplantation 2006;81:1027-34.
4. Clark DA, Lea RG, Flanders KC, Banwatt D, Chaouat G. Role of a unique species of TGF-β in preventing rejection of the conceptus during pregnancy. In: Gergely J, Benczur M, Erdei N, eds. Progress in Immunology VIII. Budapest: Springer-Verlag, 1992:841-52.
5. Ivnitsky I, Torchinsky A, Gorivodsky M, et al. TNF-α expression in embryos exposed to a teratogen. Am J Reprod Immunol 1998; 40:431-40.
6. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991;88:3069-73.
7. Out HJ, Kooijman CD, Bruinse HW, Derksen RH. Histo-pathological findings from patients with intrauterine fetal death and antiphospholipid antibodies. Eur J Obstet Gynecol 1991;41:179-86.
8. Shurtz-Swirsky R, Inbar O, Blank M, et al. In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy. Am J Reprod Immunol 1993;29:206-10.
9. Quenby S, Mountfield S, Cartwright JE, Whitley GS, Chamley L, Vince G. Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil Steril 2005;83:691-8.
10. Salmon JE, Girardi G. The role of complement in the antiphospholipid syndrorme. Curr Dir Autoimmun 2004;7:133-48.
11. Shoenfeld Y, Sherer Y, Fishman P. Interleukin-3 and pregnancy loss in antiphospholipid syndrome. Scand J Rheumatol Suppl 1998;107:19-22.
12. Fishman P, Falach-Vaknine E, Zigelman R, et al. Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 1993;91:1834-7.
13. Krause I, Blank M, Levi Y, Koike T, Barak V, Shoenfeld Y. Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression. Clin Exp Immunol 1999;117:190-7.
14. Bertolaccini ML, Atsumi T, Lanchbury JS, et al. Plasma tumor necrosis factor alpha levels and the 238A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost 2001;85:198-203.
15. Forastiero RR, Martinuzzo ME, de Larranaga GF. Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies. Lupus 2005;14:129-36.
16. Coulam CB, Krysa L, Stern JJ, Bustillo M. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995;34:333-7.
17. Balasch J, Creus M, Fabregues F, Font J, Martorell J, Vanrell JA. Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer. Fertil Steril 1996;65:655-8.
18. Elram T, Simon A, Israel S, Revel A, Shveiky D, Laufer N. Treatment of recurrent IVF failure and human leukocyte antigen similarity by intravenous immunoglobulin. Reprod Biomed Online 2005;11:745-9.
19. Sher G, Zouves C, Feinman M, et al. A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. Am J Reprod Immunol 1998;39:391-4.
20. Sher G, Matzner W, Feinman M, et al. The selective use of heparin/ aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody positive women undergoing in vitro fertilization. Am J Reprod Immunol 1998;40:74-82.
21. Clark DA, Coulam CB, Stricker RB. Is intravenous immunoglobulin (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fall in vitro fertilization and embryo transfer (IVF). J Assist Reprod Genet 2006;23:1-13.
22. Daya S, Gunby J, Clark DA. Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis. Am J Reprod Immunol 1998;39:69-76.
23. Porter TE LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006;19:CD000112.
24. Van Den Heuvel MJ, Hatta K, Peralta CG, et al. Suppression of elevated blood NKT cells in recurrent pregnancy failure patients given IVIG correlates with successful pregnancy [Abstract]. AJR Am J Roentegnol 2007;57:308-52.
25. Carp HJA, Toder V, Gazit E, Ahiron R, Mashiach S, Shoenfeld Y. Further experience with intravenous immunoglobulin in women with recurrent miscarriage and a poor prognosis. Am J Reprod Immunol 2001;46:268-73.
26. Hutton B, Sharma R, Fergusson D, et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. Br J Obstet Gynaecol 2006;114:134-42.
27. Caccavo D, Vaccaro F, Ferri GM, Amoroso A, Bonomo L. Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use. J Autoimmun 1994;7:537-48.
28. Sherer Y, Levy Y, Shoenfeld Y. Intravenous immunoglobulin therapy of antiphospholipid syndrome. Rheumatology 2000;39:421-6.
29. Bakimer R, Gilburd B, Zurgil N, Shoenfeld Y. The effect of intravenous gammaglobulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathol 1993;69:97-102.
30. Galli M, Cortelazzo S, Barbui T. In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanisms. Am J Hematol 1991;38: 184-8.
31. Kwak JY, Quilty EA, Gilman-Sachs A, Beaman KD, Beer AE. Intravenous immunoglobulin infusion therapy in women with recurrent spontaneous abortions of immune etiologies. J Reprod Immunol 1995;28:175-88.
32. Vaquero E, Lazzarin N, Valensise H, et al. Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin. Am J Reprod Immunol 2001;45:174-9.
33. Branch DW, Peaceman AM, Druzin M, et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 2000;182:122-7.
34. Carp HJA, Asherson R, Shonfeld Y. The role of intravenous immunoglobulin in pregnancies complicated by the antiphospholipid syndrome. J Clin Rheumatol 2001;7:291-4.
35. Rubio C, Rodrigo L, Perez-Cano I, et al. FISH screening of aneuploidies in preimplantation embryos to improve IVF outcome. Reprod Biomed Online 2005;11:497-506.
36. Stern JJ, Dorfman AD, Gutierez-Najar MD, et al. Frequency of abnormal karyotype among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996;65:250-3.
37. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000;73:300-4.
38. Carp HJA, Toder V, Orgad S, et al. Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001;5:678-82.
39. Ferro J, Martinez MC, Lata C, Pellicer A, Remohi J, Serra V. Improved accuracy of hysteroembryoscopic biopsies for karyotyping early missed abortions. Fertil Steril 2003;80:1260-4.
40. Takakuwa K, Asano K, Arakawa M, Yasuda M, Hasegawa I, Tanaka K. Chromosome analysis of aborted conceptuses of recurrent aborters positive for anticardiolipin antibody. Fertil Steril 1997;00168:54-8.